The Percept™ family with adaptive BrainSense™ technology automatically adjusts therapeutic stimulation to maximize motor symptom (rigidity, bradykinesia, tremor) control throughout the day and night.
The recharge-free model blends ergonomic design with cutting-edge battery technology.
The Percept™ RC device is the smallest and thinnest§ DBS rechargeable device with sensing and advanced programming capabilities.
Access on-demand DBS resources, procedural videos, webinars, and more at Medtronic Academy.
See reimbursement codes and information for Medtronic DBS.
Medtronic’s DBS therapy is approved for five indications: Parkinson’s disease, essential tremor, dystonia, obsessive-compulsive disorder (OCD), and epilepsy. Indications vary by product, refer to product labeling for details.
Humanitarian device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.
† The sensing feature of the Percept™ PC system and Percept™ RC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. The majority of patients with Parkinson’s disease have an identifiable signal. Signal may not be present or measurable in patients treated for essential tremor, dystonia, epilepsy, or obsessive-compulsive disorder. Humanitarian device: The effectiveness of these devices for the treatment of dystonia or obsessive-compulsive disorder has not been demonstrated.
‡ Medtronic DBS systems are MR Conditional. Refer to product labeling for full list of conditions.
§ Percept™ RC as compared to Boston Scientific Vercise Genus™ R16 (MP92328632-05 rev B), accessed February 6, 2025 and Abbott Liberta RC™ IPG (ARTEN600337130 A), accessed February 6, 2025.